ANALYSIS OF GENE METHYLATION SHOX2, TGFBR1, MIR-375 IN DIFFERENT TYPES OF LUNG CANCER
- Authors: Khodyrev DS1, Kulagina NS2, Brovkina OI1, Pokrovsky VE1, Gordiev MG3, Кelekhsaeva AS2, Nikitin AG1, Averyanov AV2
-
Affiliations:
- ЦБМТ ФГБУ ФНКЦ ФМБА России
- ФГБУ ФНКЦ ФМБА России
- ГАУЗ Республиканский клинический онкологический диспансер МЗ РТ
- Issue: Vol 7, No 4 (2016)
- Pages: 27-33
- Section: Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/8118
- DOI: https://doi.org/10.17816/clinpract7427-33
- ID: 8118
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
D S Khodyrev
ЦБМТ ФГБУ ФНКЦ ФМБА России
Email: DmKh008@gmail.com
кандидат биологических наук, старший научный сотрудник лаборатории генетики ЦБМТ
N S Kulagina
ФГБУ ФНКЦ ФМБА России
Email: nskulagina@gmail.com
врач-пульмонолог
O I Brovkina
ЦБМТ ФГБУ ФНКЦ ФМБА России
Email: brov.olia@gmail.com
кандидат биологических наук, старший научный сотрудник лаборатории генетики ЦБМТ
V E Pokrovsky
ЦБМТ ФГБУ ФНКЦ ФМБА России
Email: vasiliy.pokrovsky@gmail.com
врач приемного отделения ЦБМТ
M G Gordiev
ГАУЗ Республиканский клинический онкологический диспансер МЗ РТ
Email: marat7925@gmail.com
заведующий Молекулярно-диагностической лабораторией
A S Кelekhsaeva
ФГБУ ФНКЦ ФМБА Россиикандидат медицинских наук, врач-эндоскопист
A G Nikitin
ЦБМТ ФГБУ ФНКЦ ФМБА России
Email: avialn@gmail.com
кандидат биологических наук, заведующий лабораторией генетики ЦБМТ
A V Averyanov
ФГБУ ФНКЦ ФМБА России
Email: averyanovav@mail.ru
заведующий отделением пульмонологии ФНКЦ ФМБА России, руководитель Центра биомедицинских технологий, д.м.н.
References
- Robertson K.D. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610.
- Ting A.H., McGarvey K.M., Baylin S.B. The cancer epigenome-components and functional correlates. Genes Dev 2006; 20: 3215-3231.
- Shen H., Laird P.W. Interplay between the cancer genome and epigenome. Cell 2013; 153: 38-55.
- Suva` M.L., Riggi N., Bernstein B.E. Epigenetic reprogramming in cancer. Science 2013; 339: 1567-1570.
- Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003; 3: 253-266.
- Schmidt B., Liebenberg V., Dietrich D., et. al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 2010; 10: 600.
- Qian J., Massion P.P. Role of chromosome 3q amplification in lung cancer. J Thorac Oncol 2008; 3: 212-215.
- Shen H., Gao W., Wu Y.J., et. al. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas. Biomed Pharmacother 2009; 63: 396-403.
- Dehan E., Ben-Dor A., Liao W., et. al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 2007; 56: 175-184.
- Yen C.C., Liang S.C., Jong Y.J., et. al. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. Lung Cancer 2007; 57: 292-301.
- Huang Y.T., Heist R.S., Chirieac L.R., et. al. Genome-wide analysis of survival in early-stage non- small-cell lung cancer. J Clin Oncol 2009; 27: 2660-2667.
- Dietrich D., Hasinger O., Liebenberg V., et. al. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagn Mol Pathol 2012; 21: 93-104.
- Schneider K.U., Dietrich D., Fleischhacker M., et. al. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer 2011; 11: 102.
- Schmidt B., Liebenberg V., Dietrich D., et. al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 2010; 10: 600.
- Dietrich D., Kneip C., Raji O., et. al. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol 2012; 40: 825-832.
- Kneip C., Schmidt B., Seegebarth A., et. al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 2011; 6: 1632-1638.
- Hong S., Noh H., Teng Y., et. al. SHOX2 Is a Direct miR-375 Target and a Novel Epithelial-to-Mesenchymal Transition Inducer in Breast Cancer Cells Neoplasia 2014; 16(4): 279-290.
- Shelling A.N. Mutations in inhibin and activin genes associated with human disease. Mol Cell Endocrinol 2012; 359(1-2): 113-120.
- Akhurst R.J., Hata A. Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov 2012; 11(10): 790-811.
- Bottinger E.P., Jakubczak J.L., Roberts I.S., et al. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 1997; 16(10): 2621-33.
- Amendt C., Schirmacher P., Weber H., et. al. Expression of a dominant negative type ii tgf-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma evelopment. Oncogene 1998; 17(1): 25-34.
- Ammanamanchi S., Brattain M.G. Restoration of transforming growth factor-{beta} signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J Biol Chem. 2004; 279(31): 32620-32625.
- Osada H., Tatematsu Y., Masuda A., et al. Heterogeneous transforming growth factor (TGF)-β unresponsiveness and loss of TGF-β receptor type II expression caused by histone deacetylation in lung cancer cell lines. Cancer Res. 2001; 61(22): 8331-8339.
- Rykov S.V., Khodyrev D.S., Pronina I.V., et. al. Novel miRNA genes methylated in lung tumors. Genetika 2013; 49(7): 896-901.
- Sobin L.H., Gospodarowicz M.K., Wittekind Ch. Eds. TNM Classification of Malignant Tumors, 7th ed. Wiley-Blackwell, Oxford 2009; 310 pgs.
- Travis W.D., Coby T.V., Corrin B., et. al. World Health Organization International Histological Classification of Tumours; histological typing of lung and pleural tumours. Springer 1999.
- Pasche B., Pennison M. J., Jimenez H., et. al. Transactions of the american clinical and climatological association 2014; 125.
- Dong Z., Guo W., Guo Y. et. al. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma. Am J Med Sci. 2012; 343(5): 375-381.
- Guo W., Dong Z., Guo Y., et. al. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma. Mol Biol Rep. 2012; 39(10): 9453-9462.